Tempus Wealth Planning LLC Increases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Tempus Wealth Planning LLC lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,080 shares of the exchange traded fund’s stock after purchasing an additional 236 shares during the period. Tempus Wealth Planning LLC’s holdings in SPDR S&P Biotech ETF were worth $277,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of XBI. Truist Financial Corp boosted its stake in shares of SPDR S&P Biotech ETF by 0.8% during the 2nd quarter. Truist Financial Corp now owns 32,773 shares of the exchange traded fund’s stock worth $3,038,000 after purchasing an additional 252 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $1,247,000. GAMMA Investing LLC boosted its position in SPDR S&P Biotech ETF by 7,173.3% during the third quarter. GAMMA Investing LLC now owns 1,091 shares of the exchange traded fund’s stock worth $108,000 after acquiring an additional 1,076 shares during the last quarter. Ignite Planners LLC acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $238,000. Finally, Alpha Cubed Investments LLC lifted its stake in shares of SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Alpha Cubed Investments LLC now owns 233,368 shares of the exchange traded fund’s stock worth $23,057,000 after purchasing an additional 2,176 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.3 %

Shares of NYSEARCA:XBI opened at $92.57 on Wednesday. The company has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11. The business has a fifty day simple moving average of $92.99 and a 200-day simple moving average of $96.59. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.